Mitomycin and Fluorouracil in Combination with Concomitant Radiotherapy: A Potentially Curable Approach for Locally Advanced Head and Neck Squamous Cell Carcinoma Free

The above article appeared in Japanese Journal of Clinical Oncology 35(10): 572–579 (2005). The authors would like to report that there was an error while reporting locoregional relapse-free survival (LRFS) at 3 years in this article. Reported LRFS is 89.2% with mean LRFS time of 38.2 months (95% CI 36.8, 39.5) and median LRFS time not reached. The correct LRFS is 63.1% at 3 years with mean LRFS time of 32.2 months (95% CI 29.1, 35.3) and median LRFS time not reached. The corresponding survival curve for LRFS (Figure 2) is correct.

The parts of the manuscript where these errors were printed are given below with the correct values indicated.

Page 1. Abstract: Results, line 3: 89.8 should be 63.1.

Page 5. Results, lines 3 and 4: 89.8% should be 63.1%; 38.2 months should be 32.2 months; CI should be 29.1–35.3.

Table 5. Fourth column, first and second rows: 89.8 should be 63.1; 38.2 (36.8, 39.5) should be 32.2 (29.1, 35.3).

Table 7: Fifth column, last row: 89.8 should be 63.1.

The authors would like to apologise for these errors and would like to point out that the changes will not have any impact on the basic concept of the manuscript nor any effect on the message that is being conveyed.

Author notes

1Department of Radiotherapy, King George's Medical University, Lucknow, Uttar Pradesh and 2Department of Oncology, Batra Hospital and Medical Research Center, New Delhi, India